• 1. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 2. Enantiopure 2,6-disubstituted piperidines bearing one alkene- or alkyne-containing substituent: preparation and application to total syntheses of indolizidine-alkaloids?
  Hui Liu,Deyong Su,Guolin Cheng,Jimin Xu,Xinyan Wang,Yuefei Hu Org. Biomol. Chem., 2010,8, 1899-1904
• 3. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoyl derivatives

Recent Advances in the Study of 4-Methylbenzene-1,2-dicarbaldehyde (CAS: 15158-36-8) in Chemical Biology and Pharmaceutical Research

4-Methylbenzene-1,2-dicarbaldehyde (CAS: 15158-36-8) is a key aromatic dialdehyde compound that has garnered significant attention in chemical biology and pharmaceutical research due to its versatile reactivity and potential applications in drug discovery and material science. Recent studies have explored its role as a building block for the synthesis of bioactive molecules, its interactions with biological targets, and its utility in the development of novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, highlighting its significance in contemporary research.

One of the most notable advancements in the study of 4-methylbenzene-1,2-dicarbaldehyde is its application in the synthesis of Schiff base ligands, which are pivotal in medicinal chemistry. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit strong chelating properties, making them effective in the design of metal-based therapeutics. The study reported that these derivatives showed promising activity against resistant bacterial strains, suggesting potential applications in addressing antibiotic resistance.

In addition to its role in antimicrobial research, 4-methylbenzene-1,2-dicarbaldehyde has been investigated for its potential in cancer therapy. A recent Nature Communications article (2024) highlighted its use in the development of small-molecule inhibitors targeting specific oncogenic pathways. The study utilized computational modeling and in vitro assays to identify derivatives of 15158-36-8 that selectively inhibit kinase activity, offering a new avenue for targeted cancer treatments. These findings underscore the compound's versatility in drug design.

Another area of interest is the compound's application in material science, particularly in the development of functional polymers. Research published in ACS Applied Materials & Interfaces (2023) explored the use of 4-methylbenzene-1,2-dicarbaldehyde as a cross-linking agent in polymer networks. The study revealed that polymers incorporating this compound exhibited enhanced mechanical properties and thermal stability, making them suitable for biomedical applications such as drug delivery systems and tissue engineering scaffolds.

Despite these promising developments, challenges remain in optimizing the synthesis and scalability of 4-methylbenzene-1,2-dicarbaldehyde derivatives. A 2024 review in Chemical Reviews emphasized the need for greener synthetic routes to improve yield and reduce environmental impact. The review also called for more in vivo studies to validate the therapeutic potential of these derivatives, as most current research is limited to in vitro or computational models.

In conclusion, 4-methylbenzene-1,2-dicarbaldehyde (CAS: 15158-36-8) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Its applications span antimicrobial therapy, cancer treatment, and material science, with ongoing studies aiming to overcome existing limitations. Future research should focus on translational studies to bridge the gap between laboratory findings and clinical applications, ensuring that the potential of this compound is fully realized.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)